Why this matters to buyers
This trade investigation introduces uncertainty into U.S.-Germany trade relations. Buyers sourcing pharmaceuticals or related chemicals from Germany may face potential future trade disruptions or policy changes.
Recommended buyer actions
- Monitor the progress and outcome of the Section 301 investigation for any announcements of tariffs or trade restrictions.
- Assess supply chain dependencies on German pharmaceutical or chemical products and consider diversifying sourcing options as a contingency.
Original source context
The U.S. Trade Representative is investigating whether the European country's practices shift research costs on to Americans.
Read the original report · Supply Chain Dive